“HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS”. 2019. Voprosy Onkologii 65 (4): 596-602. https://doi.org/10.37469/0507-3758-2019-65-4-596-602.